People: E. I. du Pont de Nemours and Company (DD)
32.88USD
4:02pm EST
$0.69 (+2.14%)
$32.19
$32.66
$33.14
$32.29
7,194,812
8,092,034
$35.62
$16.05
Fanandakis, Nicholas
Brief Biography
Nicholas C. Fanandakis was appointed as Senior Vice President effective September 1, 2009 and Chief Financial Officer effective November 1, 2009. He was named to the position of Group Vice President- Applied BioSciences, in January 2008. Prior to that, he was vice president and general manager- DuPont Chemical Solutions Enterprise from September 2003 through September 2006 and vice president- Corporate Plans from October 2006 through December 2007.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Kullman, Ellen | 4,443,470 |
| Fanandakis, Nicholas | -- |
| Keefer, Jeffrey | 4,286,210 |
| Connelly, Thomas | 3,638,020 |
| Borel, James | -- |
| Vergnano, Mark | -- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
